PD-L1 inhibitory peptide TFA is an inhibitory peptide targeting programmed cell death ligand 1 (PD-L1). It binds to PD-L1, lifting immune suppression and restoring the antitumor activity of T cells. PD-L1 inhibitory peptide TFA shows potential for use in cancer research.
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
